Back to Feed
Seed

Punto Health raises £2m in seed funding co-led by Shilling and Plus Partners to expand its cognitive care platform.

Punto Health

The seed round was co-led by Shilling and Plus Partners to accelerate commercial expansion across the UK and Spain.

£2.0MSeed

Punto Health builds an artificial intelligence driven platform designed for early detection and personalised support in dementia and cognitive care. The full stack system connects patients, carers, and clinicians through digital biomarkers and daily care routines.

Punto Health has secured £2m in a seed funding round co-led by Shilling and Plus Partners. Additional participation came from Exceptional Ventures, Heartfelt, Fondo Bolsa Social, and ABAC Nest. The capital will be directed towards accelerating product development and driving commercial expansion across the United Kingdom and Spain.

The London based startup combines speech based digital biomarkers with personalised daily care routines and clinician dashboards. The platform has already been deployed across healthcare services in Britain and Spain, including pilots with the NHS and leading hospitals in Barcelona. Founded in 2023, the company aims to address a critical shortage of innovation in neurodegenerative care.


From the founder

"Dementia is never just one person’s disease. It affects entire families, and carers often carry an enormous invisible burden."
AM

Anna Muñoz-Farré

CEO and co-founder at Punto Health


Investor perspective

"Innovation in this area has lagged behind for too long. Punto Health is changing that. Anna and Jack are developing a clinically rigorous AI platform that provides families and healthcare professionals with tools that set a new standard for early detection and personalised care for neurodegenerative diseases. We believe this team is uniquely positioned to expand a solution that will define a category in the healthcare system."
TG

Tomás Güida

Investment Manager, Shilling


Use of funds

  1. 01Continue product development
  2. 02Expand into international markets

Investors

S

Tomás Güida

Shilling

PP

Oriol Juncosa

Plus Partners

EV

Exceptional Ventures

H

Heartfelt

FB

Fondo Bolsa Social

AN

ABAC Nest


Categories

AI/MLHealthTechSaaSMobile App

About the company

Punto Health

Punto Health

Punto Health develops an artificial intelligence powered platform for dementia and cognitive care.

London, UK Founded 2023 Website
£2.6MRaised